Clinical Trial Update: Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC [Phase 2]

View source ↗

Summary

Phase 2 study comparing a cisplatin/vinorelbine/bevacizumab regimen followed by docetaxel/gemcitabine/bevacizumab versus cisplatin/docetaxel/bevacizumab in loca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED